REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Five-year, $11.2m Enterprise Agreement

16 Aug 2022 07:00

RNS Number : 0763W
Sopheon PLC
16 August 2022
 

SOPHEON PLC

("Sopheon" or the "Company")

Sopheon and Team Submarine confirm Five-year, $11.2m Enterprise Agreement

Deployment within Naval Sea Systems Command of the US Navy will help modernize engineering, manpower and training processes

Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, announced today that Team Submarine, a grouping of submarine programs within the Naval Sea Systems Command (NAVSEA)-the largest of the U.S. Navy's six system commands-will use Sopheon's flagship solution Accolade® to modernize numerous processes related to the engineering of and training for new submarines in a five-year, $11.2 million enterprise agreement.

 

In the face of changing demands and cyclical technology improvements, Accolade will help Team Submarine modernize and manage its strategy and innovation planning and build alignment between changing strategic plans and innovation initiatives. Accolade will help ensure resources are allocated to the right mix of capabilities and those with the most potential are rapidly developed and delivered.

 

Accolade will also allow Team Submarine to replace outdated manual training tools and communication channels with a dynamic automated system that will give sailors the most comprehensive and efficient training necessary to operate advanced, highly technical submarines.

 

The agreement extends Sopheon's partnership with NAVSEA. In 2021, Accolade became the first commercial cloud innovation management platform to achieve Authority to Operate (ATO) for NAVSEA, exceeding the U.S. Navy's rigorous Risk Management Framework. Today's announcement further solidifies Sopheon as a trusted innovation partner for a wide range of governmental organizations.

 

Achieved following a substantial investment of time and effort, this material five-year arrangement will help to underpin financial goals for current and future years. Further information will be included in Sopheon's upcoming half-year report, due for publication on 24 August 2022.

 

"Sopheon is delighted to partner with Team Submarine and to extend our growing relationship with the U.S. Government," said Greg Coticchia, CEO of Sopheon. "It is an honor to work with the best on one of the most advanced technology roadmaps known to industry. We look forward to great success in this partnership with Team Submarine and helping them achieve their goals for many years."

 

 

For further information contact:

Andy Michuda (Executive Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Edward Whiley (Corporate Finance)

Alice Lane/Sunila de Silva (ECM)

finnCap

+ 44 (0) 20 7220 0500

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR").

Sopheon and Accolade are trademarks of Sopheon plc. All other trademarks are the property of their respective owners.

About Team Submarine. Team Submarine is a combination of Program Executive Office (PEO) Strategic Submarine (PEO SSBN), PEO Attack Submarines (PEO SSN), and PEO Undersea Warfare Systems (PEO UWS).The Team Submarine concept divides the single submarine-centric organization into specific PEOs with the goal of enhancing the structures and processes in the submarine research, development, acquisition, and maintenance communities. Team Submarine provides exceptional communication among the various offices that contribute to the overall success of the United States Submarine Force.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEASPSFLSAEFA
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.